Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

Anti-VEGF antibody therapy with bevacizumab provides significant clinical benefit in patients with recurrent glioblastoma multiforme (GBM). Unfortunately, progression on bevacizumab therapy is often associated with a diffuse disease recurrence pattern, which limits subsequent therapeutic options. Th...

Full description

Bibliographic Details
Main Authors: Huveldt, Deborah, Lewis-Tuffin, Laura J., Carlson, Brett L., Schroeder, Mark A., Rodriguez, Fausto, Giannini, Caterina, Galanis, Evanthia, Sarkaria, Jann N., Anastasiadis, Panos Z.
Format: Online
Language:English
Published: Public Library of Science 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572988/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572988/

Similar Items